
News|Articles|June 1, 2006
Pipeline Preview (June 2006)
Human papillomavirus (HPV) (types 6, 11, 16, 18) vaccine (Gardasil, Merck) for female patients aged 9 years or older
Advertisement
Recommendations for approval
Approvable designations
Fast-track designations
Nonapprovable designations
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Neffy’s first year: $72.2m in sales, 10,000 schools and broadening payer access
2
Brukinsa/rituximab cuts progression risk 43% in mantle cell lymphoma
3
Key Takeaways, Study Limitations, and the Broader Implications of CROWN for Patients, Providers, and Payers
4
































